These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9055185)

  • 1. Absorption of ciprofloxacin and norfloxacin when administered as niosome-encapsulated inclusion complexes.
    D'Souza SA; Ray J; Pandey S; Udupa N
    J Pharm Pharmacol; 1997 Feb; 49(2):145-9. PubMed ID: 9055185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin and norfloxacin pharmacokinetics and prostatic fluid penetration in dogs after multiple oral dosing.
    Albarellos GA; Montoya L; Waxman S; Kreil V; Ambros LA; Hallu R; Rebuelto M
    Vet J; 2006 Sep; 172(2):334-9. PubMed ID: 15994101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery.
    Moazeni E; Gilani K; Sotoudegan F; Pardakhty A; Najafabadi AR; Ghalandari R; Fazeli MR; Jamalifar H
    J Microencapsul; 2010; 27(7):618-27. PubMed ID: 20681747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antacid interaction with new quinolones: dose regimen recommendations based on pharmacokinetic modeling of clinical data for ciprofloxacin, gatifloxacin and norfloxacin and metal cations.
    Miyata K; Ohtani H; Tsujimoto M; Sawada Y
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):63-70. PubMed ID: 17256452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolone pharmacokinetics and metabolism.
    Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonstoichiometric hydroxyapatite-anionic collagen composite as support for the double sustained release of gentamicin and norfloxacin/ciprofloxacin.
    Amaro Martins VC; Goissis G
    Artif Organs; 2000 Mar; 24(3):224-30. PubMed ID: 10759646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of liposomes and niosomes on skin permeation of enoxacin.
    Fang JY; Hong CT; Chiu WT; Wang YY
    Int J Pharm; 2001 May; 219(1-2):61-72. PubMed ID: 11337166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin based nanosponge of norfloxacin: Intestinal permeation enhancement and improved antibacterial activity.
    Mendes C; Meirelles GC; Barp CG; Assreuy J; Silva MAS; Ponchel G
    Carbohydr Polym; 2018 Sep; 195():586-592. PubMed ID: 29805015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies on the pharmacokinetics of norfloxacin in chickens, turkeys and geese after a single oral administration.
    Laczay P; Semjén G; Nagy G; Lehel J
    J Vet Pharmacol Ther; 1998 Apr; 21(2):161-4. PubMed ID: 9597656
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of an ophthalmic formulation containing ciprofloxacin-hydroxypropyl-b-cyclodextrin complex.
    Nijhawan R; Agarwal SP
    Boll Chim Farm; 2003 Jun; 142(5):214-9. PubMed ID: 14526654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation of norfloxacin-loaded liposomes and their in-vitro evaluation in pig's eye.
    Lin HH; Ko SM; Hsu LR; Tsai YH
    J Pharm Pharmacol; 1996 Aug; 48(8):801-5. PubMed ID: 8887728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ciprofloxacin.
    Bergan T; Dalhoff A; Rohwedder R
    Infection; 1988; 16 Suppl 1():S3-13. PubMed ID: 3286512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related differences in norfloxacin pharmacokinetic behaviour following intravenous and oral administration in sheep.
    González F; Rodríguez C; Nieto J; De Vicente ML; San Andrés MD; San Andrés MI
    Vet Q; 1997 Nov; 19(4):145-50. PubMed ID: 9413109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation.
    Webb MS; Boman NL; Wiseman DJ; Saxon D; Sutton K; Wong KF; Logan P; Hope MJ
    Antimicrob Agents Chemother; 1998 Jan; 42(1):45-52. PubMed ID: 9449259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
    Papich MG
    Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and pharmacokinetics of liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs.
    Chen H; Gao J; Wang F; Liang W
    Drug Deliv; 2007 Apr; 14(4):201-8. PubMed ID: 17497352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin.
    Lehto P; Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):82-5. PubMed ID: 8148225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.